(R)-lipoic acid decreases expression ISO Pah (Mus musculus) 6480464 Thioctic Acid results in decreased expression of PAH mRNA CTD PMID:19555370 17beta-estradiol decreases expression ISO PAH (Homo sapiens) 6480464 Estradiol results in decreased expression of PAH mRNA CTD PMID:20106945 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PAH mRNA CTD PMID:32145629 2,3',4,4',5-Pentachlorobiphenyl affects expression ISO Pah (Mus musculus) 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Pah (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PAH mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PAH promoter] CTD PMID:16214954 and PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PAH mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Pah (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PAH mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO PAH (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PAH mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PAH mRNA CTD PMID:21215274 and PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PAH mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Pah (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PAH mRNA CTD PMID:18796159 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Pah (Mus musculus) 6480464 3 more ... CTD PMID:19467301 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin analog results in decreased expression of PAH protein and alpha-Chlorohydrin results in decreased expression of PAH protein CTD PMID:26597043 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of PAH mRNA CTD PMID:28522335 3-methylcholanthrene decreases expression ISO PAH (Homo sapiens) 6480464 Methylcholanthrene results in decreased expression of PAH mRNA CTD PMID:22579512 4-hydroxy-TEMPO decreases expression ISO Pah (Mus musculus) 6480464 tempol results in decreased expression of PAH mRNA CTD PMID:19555370 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PAH mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO Pah (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of PAH mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO PAH (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of PAH gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO PAH (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of PAH mRNA CTD PMID:27153756 aflatoxin B1 affects expression ISO PAH (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of PAH protein CTD PMID:20106945 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PAH mRNA CTD PMID:16483693 astaxanthin decreases expression ISO Pah (Mus musculus) 6480464 astaxanthine results in decreased expression of PAH mRNA CTD PMID:19555370 atazanavir sulfate multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of PAH mRNA CTD PMID:33819548 azathioprine decreases expression ISO PAH (Homo sapiens) 6480464 Azathioprine results in decreased expression of PAH mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO Pah (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PAH mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO PAH (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of PAH promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO PAH (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of PAH 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO PAH (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of PAH mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO PAH (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 Benzo[k]fluoranthene decreases expression ISO PAH (Homo sapiens) 6480464 benzo(k)fluoranthene results in decreased expression of PAH mRNA CTD PMID:22579512 beta-naphthoflavone decreases expression ISO PAH (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of PAH mRNA CTD PMID:19737606 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PAH mRNA and bisphenol A results in decreased expression of PAH protein CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PAH mRNA CTD PMID:34947998 bisphenol A affects expression ISO PAH (Homo sapiens) 6480464 bisphenol A affects the expression of PAH mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PAH mRNA CTD PMID:30903817 bisphenol A increases expression ISO Pah (Mus musculus) 6480464 bisphenol A results in increased expression of PAH mRNA CTD PMID:25594700 and PMID:30245210 buta-1,3-diene decreases expression ISO Pah (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of PAH mRNA CTD PMID:29038090 caffeine decreases phosphorylation ISO PAH (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of PAH protein CTD PMID:35688186 carbon nanotube decreases expression ISO Pah (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 chenodeoxycholic acid multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PAH mRNA more ... CTD PMID:33819548 chrysene decreases expression ISO PAH (Homo sapiens) 6480464 chrysene results in decreased expression of PAH mRNA CTD PMID:22579512 ciprofibrate decreases expression ISO Pah (Mus musculus) 6480464 ciprofibrate results in decreased expression of PAH mRNA CTD PMID:12771043 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PAH mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PAH mRNA CTD PMID:24386269 coenzyme Q10 decreases expression ISO Pah (Mus musculus) 6480464 coenzyme Q10 results in decreased expression of PAH mRNA CTD PMID:19555370 copper(II) sulfate decreases expression ISO PAH (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of PAH mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO Pah (Mus musculus) 6480464 Asbestos and Crocidolite results in increased expression of PAH mRNA CTD PMID:19446018 curcumin decreases expression ISO Pah (Mus musculus) 6480464 Curcumin results in decreased expression of PAH mRNA CTD PMID:19555370 cyclosporin A decreases expression ISO PAH (Homo sapiens) 6480464 Cyclosporine results in decreased expression of PAH mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of PAH mRNA CTD PMID:33819548 deoxycholic acid multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PAH mRNA more ... CTD PMID:33819548 dibenz[a,h]anthracene decreases expression ISO PAH (Homo sapiens) 6480464 1 more ... CTD PMID:22579512 diquat decreases expression ISO Pah (Mus musculus) 6480464 Diquat results in decreased expression of PAH mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO PAH (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAH mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PAH mRNA CTD PMID:29391264 entinostat increases expression ISO PAH (Homo sapiens) 6480464 entinostat results in increased expression of PAH mRNA CTD PMID:26272509 entinostat multiple interactions ISO PAH (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAH mRNA CTD PMID:27188386 fenthion increases expression ISO Pah (Mus musculus) 6480464 Fenthion results in increased expression of PAH mRNA CTD PMID:34813904 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PAH mRNA CTD PMID:19299419 and PMID:24793618 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of PAH mRNA CTD PMID:24136188 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of PAH mRNA CTD PMID:24915197 glycochenodeoxycholic acid multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PAH mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PAH mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PAH mRNA more ... CTD PMID:33819548 Indeno[1,2,3-cd]pyrene decreases expression ISO PAH (Homo sapiens) 6480464 indeno(1 more ... CTD PMID:22579512 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of PAH mRNA CTD PMID:36868495 iodide salt increases expression EXP 6480464 Iodides deficiency results in increased expression of PAH protein CTD PMID:26795019 kojic acid decreases expression ISO PAH (Homo sapiens) 6480464 kojic acid results in decreased expression of PAH mRNA CTD PMID:16595896 lipoic acid decreases expression ISO Pah (Mus musculus) 6480464 Thioctic Acid results in decreased expression of PAH mRNA CTD PMID:19555370 lycopene decreases expression ISO Pah (Mus musculus) 6480464 lycopene results in decreased expression of PAH mRNA CTD PMID:19555370 lysophosphatidylcholine multiple interactions ISO Pah (Mus musculus) 6480464 Lysophosphatidylcholines results in increased activity of [PAH protein binds to PAH protein binds to PAH protein binds to PAH protein] CTD PMID:19367645 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PAH mRNA CTD PMID:30467583 methidathion increases expression ISO Pah (Mus musculus) 6480464 methidathion results in increased expression of PAH mRNA CTD PMID:34813904 mono(2-ethylhexyl) phthalate increases expression ISO Pah (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PAH mRNA CTD PMID:22401849 N-ethylmaleimide multiple interactions ISO Pah (Mus musculus) 6480464 Ethylmaleimide results in increased activity of [PAH protein binds to PAH protein binds to PAH protein binds to PAH protein] CTD PMID:19367645 N-nitrosodiethylamine decreases expression ISO PAH (Homo sapiens) 6480464 Diethylnitrosamine results in decreased expression of PAH mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PAH mRNA CTD PMID:17602206 N-nitrosodiethylamine decreases expression ISO Pah (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of PAH mRNA CTD PMID:12771043 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of PAH protein CTD PMID:19716841 naphthalene decreases expression ISO PAH (Homo sapiens) 6480464 naphthalene results in decreased expression of PAH mRNA CTD PMID:22579512 nefazodone multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of PAH mRNA CTD PMID:33819548 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of PAH mRNA CTD PMID:33484710 O-acetyl-L-carnitine decreases expression ISO Pah (Mus musculus) 6480464 Acetylcarnitine results in decreased expression of PAH mRNA CTD PMID:19555370 O-methyleugenol decreases expression ISO PAH (Homo sapiens) 6480464 methyleugenol results in decreased expression of PAH mRNA CTD PMID:32234424 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PAH protein CTD PMID:16538041 paracetamol multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of PAH mRNA CTD PMID:33819548 paracetamol decreases expression ISO PAH (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PAH mRNA CTD PMID:29067470 paracetamol multiple interactions ISO Pah (Mus musculus) 6480464 [CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in decreased expression of PAH protein CTD PMID:25499718 paracetamol increases expression ISO PAH (Homo sapiens) 6480464 Acetaminophen results in increased expression of PAH mRNA CTD PMID:26690555 paracetamol affects expression ISO Pah (Mus musculus) 6480464 Acetaminophen affects the expression of PAH mRNA CTD PMID:17562736 perfluorononanoic acid decreases expression ISO PAH (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of PAH mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO PAH (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of PAH mRNA CTD PMID:25868421 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PAH protein CTD PMID:34958885 phenanthrene decreases expression ISO PAH (Homo sapiens) 6480464 phenanthrene results in decreased expression of PAH mRNA CTD PMID:22579512 pirinixic acid multiple interactions ISO Pah (Mus musculus) 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of PAH mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO Pah (Mus musculus) 6480464 pirinixic acid results in decreased expression of PAH mRNA CTD PMID:16221962 and PMID:20813756 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PAH mRNA CTD PMID:17164430 potassium dichromate increases expression ISO Pah (Mus musculus) 6480464 Potassium Dichromate results in increased expression of PAH mRNA CTD PMID:23608068 propiconazole increases metabolic processing ISO Pah (Mus musculus) 6480464 propiconazole results in increased metabolism of PAH protein CTD PMID:19714882 quercetin decreases expression ISO PAH (Homo sapiens) 6480464 Quercetin results in decreased expression of PAH mRNA CTD PMID:21632981 resveratrol decreases expression ISO Pah (Mus musculus) 6480464 resveratrol results in decreased expression of PAH mRNA CTD PMID:19555370 S-methylcysteine increases oxidation ISO Pah (Mus musculus) 6480464 PAH protein results in increased oxidation of S-methylcysteine CTD PMID:19367645 SB 431542 multiple interactions ISO PAH (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAH mRNA CTD PMID:27188386 sodium arsenite affects methylation ISO PAH (Homo sapiens) 6480464 sodium arsenite affects the methylation of PAH gene CTD PMID:28589171 sodium arsenite increases expression ISO Pah (Mus musculus) 6480464 sodium arsenite results in increased expression of PAH protein CTD PMID:29044176 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PAH protein CTD PMID:29459688 sodium arsenite decreases expression ISO PAH (Homo sapiens) 6480464 sodium arsenite results in decreased expression of PAH mRNA CTD PMID:29301061 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of PAH mRNA CTD PMID:22110744 streptozocin multiple interactions EXP 6480464 peroxovanadate inhibits the reaction [Streptozocin results in increased activity of PAH protein] and peroxovanadate inhibits the reaction [Streptozocin results in increased expression of PAH mRNA] CTD PMID:11055810 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of PAH mRNA CTD PMID:11055810 streptozocin increases activity EXP 6480464 Streptozocin results in increased activity of PAH protein CTD PMID:11055810 Sunset Yellow FCF multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of PAH mRNA CTD PMID:33819548 tartrazine multiple interactions ISO PAH (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PAH mRNA CTD PMID:33819548 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of PAH mRNA CTD PMID:15885361 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of PAH mRNA CTD PMID:21515302 tetrachloromethane multiple interactions ISO Pah (Mus musculus) 6480464 CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of PAH mRNA] CTD PMID:17084009 tetrachloromethane multiple interactions EXP 6480464 [Olive Oil analog co-treated with Carbon Tetrachloride] affects the expression of PAH protein CTD PMID:25303780 tetrachloromethane decreases expression ISO Pah (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of PAH mRNA CTD PMID:17084009 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PAH mRNA CTD PMID:16178884 tetrachloromethane decreases activity EXP 6480464 Carbon Tetrachloride results in decreased activity of PAH protein CTD PMID:16139311 tetracycline decreases expression ISO Pah (Mus musculus) 6480464 Tetracycline results in decreased expression of PAH mRNA CTD PMID:24489787 tetraphene decreases expression ISO PAH (Homo sapiens) 6480464 benz(a)anthracene results in decreased expression of PAH mRNA CTD PMID:22579512 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PAH mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Pah (Mus musculus) 6480464 titanium dioxide results in increased expression of PAH mRNA CTD PMID:23557971 trichloroethene increases expression ISO Pah (Mus musculus) 6480464 Trichloroethylene results in increased expression of PAH mRNA CTD PMID:19254012 urethane decreases expression ISO PAH (Homo sapiens) 6480464 Urethane results in decreased expression of PAH mRNA CTD PMID:28818685 valproic acid decreases expression ISO PAH (Homo sapiens) 6480464 Valproic Acid results in decreased expression of PAH mRNA CTD PMID:29154799 valproic acid increases expression ISO PAH (Homo sapiens) 6480464 Valproic Acid results in increased expression of PAH mRNA CTD PMID:28001369 vancomycin increases expression ISO Pah (Mus musculus) 6480464 Vancomycin results in increased expression of PAH mRNA CTD PMID:18930951